The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis

Med Ultrason. 2010 Jun;12(2):145-9.

Abstract

Liver cirrhosis is a major risk factor for the development of hepatocellular carcinoma, hence the need to screen those patients by means of liver ultrasound every 6 months. The differential diagnosis between a regenerative nodule, a dysplastic one and hepatocellular carcinoma is made based on a contrast imaging method (CEUS, MRI or CT) as they all have comparative sensitivities.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular / diagnostic imaging*
  • Carcinoma, Hepatocellular / pathology
  • Contrast Media*
  • Diagnosis, Differential
  • Humans
  • Liver Cirrhosis / diagnostic imaging*
  • Liver Cirrhosis / pathology
  • Liver Neoplasms / diagnostic imaging*
  • Liver Neoplasms / pathology
  • Magnetic Resonance Imaging
  • Risk Factors
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed
  • Ultrasonography

Substances

  • Contrast Media